Di Minno, G. and Ravasio, R. (2021) “Cost-effectiveness analysis of caplacizumab in the new standard of care for immune Thrombotic Thrombocytopenic Purpura in Italy”, Global and Regional Health Technology Assessment, 8(1), pp. 43–52. doi: 10.33393/grhta.2021.2191.